VAM
AMAG

Visium Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Visium Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,890,200
Closed -$60.3M – 1247
2014
Q3 		$60.3M Sell
1,890,200
-180,670
-9% -$3.85M 0.89% 12
2014
Q2 		$42.9M Buy
2,070,870
+70,670
+4% +$1.31M 0.67% 19
2014
Q1 		$38.7M Buy
+2,000,200
New +$42.5M 0.63% 24

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Visium Asset Management's AMAG Position: Q4 2014 in Review

Visium Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2014, closing a stake of 1,890,200 shares — an estimated $60.3M sold.

Visium Asset Management first reported a position in AMAG in Q1 2014 and held it in 3 quarters. The position peaked at $60.3M in Q3 2014. 154 funds tracked by Wall St. Rank hold AMAG as of Q4 2014.

  • Visium Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Visium Asset Management sold 1,890,200 AMAG Pharmaceuticals shares in Q4 2014, an estimated $60.3M.
  • Visium Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • Visium Asset Management's AMAG Pharmaceuticals position peaked at $60.3M in Q3 2014.
  • 154 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2014.

Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.